Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

Matthew H. Law; D. Timothy Bishop; Jeffrey E. Lee; Myriam Brossard; Nicholas G. Martin; Eric K. Moses; Fengju Song; Jennifer H. Barrett; Rajiv Kumar; Douglas F. Easton; Paul D.P. Pharoah; Anthony J. Swerdlow; Katerina Kypreou; John Taylor; Mark Harland; Juliette A. Randerson‐Moor; Lars A. Akslen; Per Arne Andresen; Marie-Françoise Avril; Esther Azizi; Giovanna Bianchi‐Scarrà; Kevin M Brown; Tadeusz Dębniak; David L Duffy; David E. Elder; Shenying Fang; Eitan Friedman; Pilar Galán; Paola Ghiorzo; Elizabeth M. Gillanders; Alisa M. Goldstein; Nelleke A. Gruis; Johan Hansson; Per Helsing; Marko Hočevar; Veronica Höiom; Christian Ingvar; Peter A. Kanetsky; Wei V. Chen; Essen-Heidelberg Investigators; The SDH Study Group; Q-MEGA and QTWIN Investigators; AMFS Investigators; ATHENS Melanoma Study Group; Maria Teresa Landi; Julie Lang; G.M. Lathrop; Jan Lubiński; Rona M. MacKie; Graham J. Mann; Anders Molven; Grant W. Montgomery; Srdjan Novaković; Håkan Olsson; Susana Puig; Joan Anton Puig‐Butille; Abrar A. Qureshi; Graham Radford‐Smith; Nienke van der Stoep; Remco van Doorn; David C. Whiteman; Jamie E. Craig; Dirk Schadendorf; Lisa A. Simms; Kathryn P. Burdon; Dale R. Nyholt; Karen A. Pooley; Nick Orr; Alexander J. Stratigos; Anne Ε. Cust; Sarah V. Ward; Nicholas K. Hayward; Jiali Han; H. J. Schulze; Alison M. Dunning; Julia Newton‐Bishop; Florence Démenais; Christopher I. Amos; Stuart MacGregor; Mark M. Iles

doi:10.1038/ng.3373

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

Matthew H. Law(QIMR Berghofer Medical Research Institute), D. Timothy Bishop(University of Leeds), Jeffrey E. Lee(The University of Texas MD Anderson Cancer Center), Myriam Brossard(Inserm), Nicholas G. Martin(QIMR Berghofer Medical Research Institute), Eric K. Moses(The University of Western Australia), Fengju Song(Tianjin Medical University Cancer Institute and Hospital), Jennifer H. Barrett(University of Leeds), Rajiv Kumar(German Cancer Research Center), Douglas F. Easton(University of Cambridge), Paul D.P. Pharoah(University of Cambridge), Anthony J. Swerdlow(Institute of Cancer Research), Katerina Kypreou(National and Kapodistrian University of Athens), John Taylor(University of Leeds), Mark Harland(University of Leeds), Juliette A. Randerson‐Moor(University of Leeds), Lars A. Akslen(Haukeland University Hospital), Per Arne Andresen(Oslo University Hospital), Marie-Françoise Avril(Délégation Paris 5), Esther Azizi(Tel Aviv University), Giovanna Bianchi‐Scarrà(Istituti di Ricovero e Cura a Carattere Scientifico), Kevin M Brown(National Institutes of Health), Tadeusz Dębniak(International Hereditary Cancer Center), David L Duffy(QIMR Berghofer Medical Research Institute), David E. Elder(University of Pennsylvania), Shenying Fang(The University of Texas MD Anderson Cancer Center), Eitan Friedman(Tel Aviv University), Pilar Galán(Inserm), Paola Ghiorzo(Istituti di Ricovero e Cura a Carattere Scientifico), Elizabeth M. Gillanders(National Institutes of Health), Alisa M. Goldstein(National Institutes of Health), Nelleke A. Gruis(Leiden University Medical Center), Johan Hansson(Karolinska University Hospital), Per Helsing(Oslo University Hospital), Marko Hočevar(Institute of Oncology Ljubljana), Veronica Höiom(Karolinska University Hospital), Christian Ingvar(Lund University), Peter A. Kanetsky(Moffitt Cancer Center), Wei V. Chen(The University of Texas MD Anderson Cancer Center), Essen-Heidelberg Investigators(National Institutes of Health), The SDH Study Group(University of Glasgow), Q-MEGA and QTWIN Investigators(McGill University and Génome Québec Innovation Centre), AMFS Investigators(International Hereditary Cancer Center), ATHENS Melanoma Study Group(Public Health Scotland), Maria Teresa Landi(The University of Sydney), Julie Lang(Haukeland University Hospital), G.M. Lathrop(QIMR Berghofer Medical Research Institute), Jan Lubiński(Institute of Oncology Ljubljana), Rona M. MacKie(Lund University), Graham J. Mann(The University of Sydney), Anders Molven(Haukeland University Hospital), Grant W. Montgomery(QIMR Berghofer Medical Research Institute), Srdjan Novaković(The University of Queensland), Håkan Olsson(Lund University), Susana Puig(Leiden University Medical Center), Joan Anton Puig‐Butille(QIMR Berghofer Medical Research Institute), Abrar A. Qureshi(Flinders University), Graham Radford‐Smith(The University of Queensland), Nienke van der Stoep(QIMR Berghofer Medical Research Institute), Remco van Doorn(University of Tasmania), David C. Whiteman(Queensland University of Technology), Jamie E. Craig(Flinders University), Dirk Schadendorf(Institute of Cancer Research), Lisa A. Simms(National and Kapodistrian University of Athens), Kathryn P. Burdon(The University of Sydney), Dale R. Nyholt(Queensland University of Technology), Karen A. Pooley(QIMR Berghofer Medical Research Institute), Nick Orr(Indiana University Health), Alexander J. Stratigos(National and Kapodistrian University of Athens), Anne Ε. Cust(The University of Sydney), Sarah V. Ward(University of Leeds), Nicholas K. Hayward(Inserm), Jiali Han(Dartmouth College), H. J. Schulze(QIMR Berghofer Medical Research Institute), Alison M. Dunning(University of Leeds), Julia Newton‐Bishop(University of Leeds), Florence Démenais(Inserm), Christopher I. Amos(Dartmouth College), Stuart MacGregor(QIMR Berghofer Medical Research Institute), Mark M. Iles(University of Leeds)

Nature Genetics

August 3, 2015

10.1038/ng.3373

Cited by 245Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis